A red blood cell distribution width (RDW) test is an important part of a complete blood count (CBC) test. It measures the range of red blood cell sizes in the body. A high RDW result can indicate anemia, inflammation, or other health conditions. In this article, we will discuss the meaning of a high RDW result, and its potential implications.
RDW is a measure of the range of red blood cell sizes in the body. It is usually expressed as a percentage. The size of red blood cells can vary from person to person, but a high RDW result indicates that the size of the red blood cells is unusually wide.
A high RDW result can indicate a number of possible health conditions. It can be a sign of anemia, which is a condition in which the body does not have enough healthy red blood cells. It can also be a sign of inflammation, which is a response of the body to infection or injury. In some cases, it can be a sign of a vitamin B12 or folate deficiency.
If a high RDW result is found on a CBC test, further tests may be needed to diagnose the cause. These tests may include a ferritin test to check for anemia, a C-reactive protein test to check for inflammation, and a vitamin B12 and folate test to check for deficiencies.
The treatment for a high RDW result will depend on the underlying cause. If the cause is anemia, iron supplements may be prescribed to increase the number of healthy red blood cells in the body. If the cause is inflammation, anti-inflammatory medication may be prescribed. If the cause is a vitamin B12 or folate deficiency, supplements may be prescribed.
A high RDW result can be a sign of several different health conditions. It is important to discuss any abnormal results with a doctor, who can order further tests to diagnose the cause. Depending on the underlying cause, treatment may involve iron supplements, anti-inflammatory medication, or vitamin B12 or folate supplements.
1.
It Is Not Just the Royals Who Go Through Cancer.
2.
Have the Harms of Lung Cancer Screening Been Exaggerated?
3.
Cancer diagnosis does not spur improvements to survivors' diets or eating habits
4.
Novel Agent for Chronic GVHD Wins FDA Approval
5.
Rising rates of head and neck cancers in England
1.
Targeted Therapy: Latest Advances, Learning Tools, Trials & Treatment Options Explained
2.
Matrix Metalloproteinases in Stroke: Broad vs. Selective Inhibition Strategies
3.
Understanding the Causes and Symptoms of Cavernous Sinus Thrombosis
4.
Red Blood Cell Microparticles: Tiny Warriors Against Bleeding in the Brain
5.
Revolutionizing Cancer Care: The Impact of Darzalex Faspro
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Clinical Insights in Hematology
2.
From Guidelines to Practice: Hematology
3.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
4.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
5.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation